IVA-360

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameIVA-360
Drug Alias NameParkinson's disease program (Inventiva)NURR1 activators (Inventiva)SLV-360IVA-360
ClassificationSmall molecules
Mechanisms of ActionNeuroprotectantsNuclear receptor subfamily 4 group A member 2 agonists
TargetsNuclear receptor subfamily 4 group A member 2
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSolvay SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott LaboratoriesSolvay SAInventiva SA
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A